fda warning letter glp-1 solution september 2025 issued 30 letters to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading Medicare's New GLP-1 Pricing Initiative

Tirzepatide carries FDA warnings for pancreatitis risk, thyroid C-cell tumors (in animal models), and rare cases of severe hypoglycemia when combined with insulin

Patients with genetic variations in GLP-1 receptors or related peptide pathways may experience enhanced response to semaglutide, while others show modest benefits

Vitamin B12 (cobalamin) is essential for red blood cell formation, neurological function, and cellular metabolism, but supplementation does not directly cause fat reduction or appetite suppression

Natural supplements generally: Produce smaller effects Work indirectly Require consistent use Depend heavily on diet and lifestyle Consumers should be skeptical of products promising medication-like weight loss results